{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:55:13Z","timestamp":1753876513116,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fibrodysplasia ossificans progressiva (FOP) is the most dramatic form of progressive heterotopic ossification of soft tissues. Hearing impairment in FOP patient is a common feature, reported by about 50% of affected patients. However, wide case series considering audiologic features are lacking. We report the audiologic history of a group of FOP patients in order to define the hearing loss characteristics, genotype association, and possible rehabilitative options. We report audiometric history of 16 FOP patients referred to our Institute from 2014 onwards without ear malformations or other known reason for audiologic impairment. Major involvement of high frequencies in our FOP cohort suggests that the position of the high-frequency receptors within the cochlea, near the oval window, makes them more exposed to damage than the low-frequency receptors located deeper in the cochlea. Furthermore, the reported gender difference may be secondary to a hormonal effect, as known in patients with otosclerosis. Finally, regarding the genotype, we noted that only the non-classic patient carrying the ACVR1 c.619C&amp;gt;G; p.Q207E mutation, presented a mixed hypoacusia with a sensorineural component prevailing on acute frequencies, currently not deserving hearing aids. This evidence suggests a possible novel genotype association to be confirmed in larger cohort. The present analysis shows that a longer disease history is associated with a statistically significant worse hearing loss, mainly involving the high frequencies. The advent of new therapeutic options highlights the relevance of having comparative follow-up data in order to evaluate the effectiveness of these new therapies against all the various clinical manifestations of FOP.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf029","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:53:41Z","timestamp":1739559221000},"source":"Crossref","is-referenced-by-count":0,"title":["Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-1742","authenticated-orcid":false,"given":"Tommaso","family":"Cacco","sequence":"first","affiliation":[{"name":"Otorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Papa","sequence":"additional","affiliation":[{"name":"Rheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Carmisciano","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Bruzzo","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Semino","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Matucci-Cerinic","sequence":"additional","affiliation":[{"name":"Rheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Di Rocco","sequence":"additional","affiliation":[{"name":"Rare Diseases Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Bocciardi","sequence":"additional","affiliation":[{"name":"Medical Genetics Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]},{"name":"Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa , 16100 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[{"name":"Rheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini , 16132 Genova ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"1","key":"2025031810230009100_ref1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1044\/1059-0889(1999\/011)","article-title":"Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva","volume":"8","author":"Levy","year":"1999","journal-title":"Am J Audiol"},{"issue":"5","key":"2025031810230009100_ref2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat Genet"},{"issue":"12","key":"2025031810230009100_ref3","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.gim.2022.08.013","article-title":"The natural history of fibrodysplasia ossificans progressiva: a prospective, global 36-month study","volume":"24","author":"Pignolo","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"2025031810230009100_ref4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/ORR.S337491","article-title":"Monitoring and management of fibrodysplasia ossificans progressiva: current perspectives","volume":"14","author":"Smilde","year":"2022","journal-title":"Orthop Res Rev"},{"issue":"1","key":"2025031810230009100_ref5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-017-0674-5","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases","volume":"12","author":"Baujat","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025031810230009100_ref6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","article-title":"Fibrodysplasia ossificans progressiva","volume":"22","author":"Kaplan","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"2025031810230009100_ref7","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jpeds.2021.02.037","article-title":"Evolving management of fibrodysplasia ossificans progressiva","volume":"232S","author":"Kannu","year":"2021","journal-title":"J Pediatr"},{"issue":"1","key":"2025031810230009100_ref8","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"1","author":"Kaplan","year":"2019","journal-title":"Proc Intl Clin Council FOP"},{"issue":"1","key":"2025031810230009100_ref9","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"2","author":"Kaplan","year":"2022","journal-title":"Proc Intl Clin Council FOP"},{"issue":"3","key":"2025031810230009100_ref10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum Mutat"},{"issue":"3","key":"2025031810230009100_ref11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jbmr.4762","article-title":"Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP)","volume":"38","author":"Pignolo","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025031810230009100_ref12","first-page":"100131","article-title":"Patterns of hearing changes in women and men from denarians to nonagenarians","volume":"9","author":"Wasano","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"20","key":"2025031810230009100_ref13","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1093\/hmg\/ddu255","article-title":"ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant","volume":"23","author":"Haupt","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2025031810230009100_ref14","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.bone.2020.115274","article-title":"Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry","volume":"134","author":"Pignolo","year":"2020","journal-title":"Bone"},{"issue":"4","key":"2025031810230009100_ref15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bone.2012.07.002","article-title":"Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects","volume":"51","author":"Morales-Piga","year":"2012","journal-title":"Bone"},{"issue":"1","key":"2025031810230009100_ref16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jclinane.2018.07.004","article-title":"Difficult airway management in a child with fibrodysplasia ossificans progressiva in status asthmaticus","volume":"51","author":"Ojo","year":"2018","journal-title":"J Clin Anesth"},{"issue":"4","key":"2025031810230009100_ref17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/lary.27520","article-title":"Simulation-guided tracheotomy in a patient with fibrodysplasia ossificans progressiva","volume":"129","author":"Padia","year":"2019","journal-title":"Laryngoscope"},{"issue":"1","key":"2025031810230009100_ref18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0165-5876(87)90053-X","article-title":"Fibrodysplasia ossificans progressiva and hearing loss","volume":"14","author":"S\u00f8rensen","year":"1987","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"2025031810230009100_ref19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0022215100068481","article-title":"Deafness in myositis ossificans progressiva","volume":"82","author":"Ludman","year":"1968","journal-title":"J Laryngol Otol"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf029\/61900431\/ziaf029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/4\/ziaf029\/61900431\/ziaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/4\/ziaf029\/61900431\/ziaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:23:42Z","timestamp":1742293422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf029\/8015732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf029","relation":{},"ISSN":["2473-4039"],"issn-type":[{"type":"electronic","value":"2473-4039"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,14]]},"article-number":"ziaf029"}}